Open AccessCOAGULASE NEGATIVE STAPHYLOCOCCUS SPECIES
Author(s) -
Eiman Syed,
Faiza Nawaz Satti,
Sumaira Mubasher,
Farhan Rasheed,
Muhammad Ilyas,
Ambereen Anwar,
Waheed uz Zaman
Publication year - 2018
Publication title -
the professional medical journal/the professional medical journal
Language(s) - English
Resource type - Journals
eISSN - 2071-7733
pISSN - 1024-8919
DOI - 10.29309/tpmj/2018.25.05.323
Subject(s) - teicoplanin , medicine , linezolid , vancomycin , clindamycin , coagulase , amikacin , cons , ciprofloxacin , erythromycin , antibiotics , microbiology and biotechnology , staphylococcus , staphylococcus aureus , biology , bacteria , computer science , genetics , programming language
Objective: Department and sample wise distribution along with drug-resistantpattern and best therapeutic choice of drugs against Coagulase-negative Staphylococcusspecies (CoNS). Study Design: Cross-sectional study. Setting: Department of MicrobiologyAIMC Lahore Pakistan. Period: 1st January 2016 to 25th May 2017. Methodology: About4597 samples were collected from various departments and processed for antimicrobialresistant testing. Results: Of 4597 samples, culture positive were 40.4% CoNS were 9.0%and 22.3% of total and total culture positive specimens respectively The highest rate isolationrate of CONS was found in ICU 32.4%, Sample-wise 34.1% in blood samples.0% resistantto Linezolid, Teicoplanin, and Vancomycin, while very high resistant rate against penicillin77.8%, Cotrimoxazole 60%, Methicillin 59.8%,Co-amoxiclav 54%,Clindamycin 48.7%,FusidicAcid 463%, Doxycycline 45.1%, Erythromycin 44.9%, Amikacin 42%, Ciprofloxacin 41.8% andGentamycin 23%. Conclusion: Linezolid, Vancomycin, and Teicoplanin are the best choice ofdrugs while emergence of drug-resistant to other basic drugs is alarming